Rhaeos
Dr. Mitali Stevens has >20 years of experience in clinical pharmacy and market access in the pharmaceutical and medical device industries. Working collaboratively with cross-functional partners, she has developed and helped to execute systematic evidence and reimbursement strategies for several companies that integrate health economics, outcomes research and market access solutions across all stages of the product life cycle to ensure competitive advantage and commercial success. Dr. Stevens received her Doctor of Pharmacy from The Ohio State University. She is a licensed pharmacist and holds a Board Certification in Pharmacotherapy Specialty.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Rhaeos
1 followers
Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow subdermally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now.